Strategies for Leukotriene Modulation in Dermatology: Even More Visionary Perspectives? An Update

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)

Volume 16, 3 Issues, 2017

Download PDF Flyer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Claudiu T. Supuran
Neurofarba Department
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Strategies for Leukotriene Modulation in Dermatology: Even More Visionary Perspectives? An Update

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 10(6): 407-417.

Author(s): Giovanni Luigi Capella.

Affiliation: Private Practice, Dermatology & STD, Via Sauli 7, 20127 Milan, Italy.


In the last decade, substantial progress has been made in the study of eicosanoid autacoids, such as leukotrienes [LTs], which were already known to be heavily involved in inflammatory skin processes. The subject has extended from the detailed description of 5-lipoxygenase cascade products and regulation to the discovery of detailed interrelations among LT physiology and apparently loosely related fields such as peroxisome-proliferating activating receptors (PPARs), pro-resolving mediators, control of fibrosing processes, and nuclear signalling. Many of these advances clearly present aspects which could be relevant to experimental and clinical dermatology. Surprisingly enough, and unfortunately due at least in part to restrictive policies in off-label use of drugs all over the world, the use of available LT modulators in dermatology has remained the same as ten years ago, with the significant but marginal exception of Sjögren-Larsson syndrome. From a dermatological viewpoint, the state of the art is far from desirable. A survey of relevant advances, with special regards to medicinal chemistry topics related to anti-inflammatory intervention is provided, together with visionary proposals for future, substantial improvement in the management of patients suffering from inflammatory skin diseases, in which LT-related pathogenetic and resolving mechanism play so important a role.


Leukotriene antagonist, Leukotriene receptor blocking agent, Lipoxygenase inhibitor, Platelet activating factor, Prostaglandin, Lipoxin, Skin diseases, Sjogren-Larsson syndrome, HISTAMINE-RECEPTOR, ANTI-LEUKO-TRIENE BOTANY.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 10
Issue Number: 6
First Page: 407
Last Page: 417
Page Count: 11
DOI: 10.2174/1871523011109060407
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science